Look for:

Our offer for

GILEAD SCIENCES INC.


ISIN:
US3755581036
WKN:
375558103

2021/03/08 12:04:08
Price
54.01 EUR
Difference 1.35% (0.72)

General attributes

ISINUS3755581036
SymbolGILD
ExchangeFrankfurt
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)68,093 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)54.09 EUR (300)
Ask (Ask size)54.16 EUR (300)
Open54.26 EUR
High54.35 EUR
Low54.01 EUR
Close (prev. day)53.29 EUR
VWAP54.14691 EUR
Volume (pcs)680
Trading volume36,819.90
Number of trades7
Last size50

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Annual report: GILEAD SCIENCES INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Erste Group related products on underlying

Product type # products
Express bonds 2

Recent research

Date Headline Download
2020/04/17 de Equity Weekly PDF Download


2021/03/08 12:04:08
Price
54.01 EUR
Difference 1.35% (0.72)

General attributes

ISINUS3755581036
SymbolGILD
ExchangeFrankfurt
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)68,093 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)54.09 EUR (300)
Ask (Ask size)54.16 EUR (300)
Open54.26 EUR
High54.35 EUR
Low54.01 EUR
Close (prev. day)53.29 EUR
VWAP54.14691 EUR
Volume (pcs)680
Trading volume36,819.90
Number of trades7
Last size50

Performance and Risk

6M1Y3Y
Perf (%)-5.38%-20.46%-16.04%
Perf (abs.)-3.03-13.71-10.18
Beta0.530.480.59
Volatility24.3534.2329.53
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)52.48 EUR (1,809)
Ø price 30 days | Ø volume 30 days (pcs.)53.88 EUR (2,251)
Ø price 100 days | Ø volume 100 days (pcs.)51.61 EUR (2,841)
Ø price 250 days | Ø volume 250 days (pcs.)59.04 EUR (5,377)
YTD High | date57.36 EUR (2021/02/08)
YTD Low | date47.14 EUR (2021/01/04)
52 Weeks High | date84.99 EUR (2020/04/17)
52 Weeks Low | date46.23 EUR (2020/12/30)

Erste Group related products on underlying

Product type # products
Express bonds 2

All listings for GILEAD SCIENCES INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2021/03/0812:4254.04 EUR0.3789
Vienna Stock Exchange2021/03/0809:0554.23 EUR0.001
Tradegate2021/03/0812:0754.24 EUR0.2149
Stuttgart2021/03/0810:4854.11 EUR0.065
SIX Swiss Exchange2020/04/1717:3585.00 USD0.001
SIX Swiss Exchange2020/05/1117:3572.00 CHF0.001
Nasdaq2021/03/0522:0064.62 USD625.9495,278
Munich2021/03/0808:0054.07 EUR0.001
London Stock Exchange European Trade Reporting2021/03/0809:0464.04 USD0.001
Hanover2021/03/0808:0254.09 EUR0.001
Hamburg2021/03/0811:3154.16 EUR0.034
Frankfurt2021/03/0812:0454.01 EUR0.047
Duesseldorf2021/03/0812:3053.91 EUR0.009
Borsa Italiana MTF Trading After Hours2021/03/0318:0152.18 EUR0.001
Borsa Italiana MTF Global Equity Market2021/03/0812:2954.11 EUR0.029
Berlin2021/03/0808:0354.40 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=1964&ID_TYPE_IMAGE_LOGO=2

Contact Details

GILEAD SCIENCES, INC.
- -
333 Lakeside Drive - 94404 Foster City
Telefon: 1-650-574-3000
Fax: 1-650-578-9264
E-mail: -

PDF Downloads

Annual report: GILEAD SCIENCES INC.PDF Download

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firms primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster, CA.

Members of Management Board

George ShultzMember of Board of Directors
Jacqueline BartonMember of Board of Directors
Jeffrey BluestoneMember of Board of Directors
John CoganMember of Board of Directors
Richard WhitleyMember of Board of Directors
Sandra HorningMember of Board of Directors
Anthony WeltersMember of Board of Directors
Gayle WilsonMember of Board of Directors
Harish M. ManwaniMember of Board of Directors
Javier RodriguezMember of Board of Directors
Kelly KramerMember of Board of Directors
Kevin LoftonMember of Board of Directors
Per Wold-OlsenMember of Board of Directors
Daniel O'DayChairman of Managing Board
Douglas MaffeiMember of Executive Committee
Linda HigginsMember of Executive Committee
Mark GenoveseMember of Executive Committee
Merdad ParseyMember of Executive Committee
Michael QuigleyMember of Executive Committee
Tomas CihlarMember of Executive Committee






Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.